Mylan Laboratories Inc. (MYL) Declares Quarterly Preferred Stock Dividend
8/1/2008 10:44:13 AM
More...
|
Mylan Laboratories Inc. (MYL) Confirms Patent Challenge Relating to Azor(R)
6/4/2008 2:32:58 PM
More...
|
Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA (MKGAF.PK)
6/2/2008 7:19:00 AM
More...
|
Mylan Laboratories Inc. (MYL) Reports Adjusted Diluted EPS of $0.09 for the Quarter Ended March 31, 2008
5/9/2008 11:13:44 AM
More...
|
Mylan Laboratories Inc. (MYL) Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
5/7/2008 6:48:50 AM
More...
|
Mylan Laboratories Inc. (MYL) Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008 Company to Provide Financial Guidance for Fiscal 2008 through 2010
5/1/2008 11:38:07 AM
More...
|
Mylan Laboratories Inc. (MYL) Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
4/30/2008 9:34:42 AM
More...
|
Mylan Laboratories Inc. (MYL) Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
2/28/2008 8:28:41 AM
More...
|
Forest Laboratories, Inc. (FRX) Announces Amendment to Bystolic(TM) (nebivolol) Agreement
2/28/2008 7:46:30 AM
More...
|
Mylan Laboratories Inc. (MYL) Announces Appointment of Patrick Vink as Senior Vice President in New Position of Global Head of Biologics
2/26/2008 7:29:13 AM
More...
|
|